SecBot SecBot

CDIO

Cardio Diagnostics Holdings, Inc.
Nasdaq· In Vitro & In Vivo Diagnostic Substances· Inc. DE· CIK 0001870144 Biotech & Drug Discovery
$1.69 −0.01 (−0.88%)
Oct 23 4:00 PM ET · prev $1.71
Market cap
$5.0M
Nano cap
Next earnings
Nov 10
in 15 days
1 year
−56.8%
from $3.91 · Oct 27
30 days
−10.8%
from $1.89
52-week range
$1.05–6.55
−74% from high · low Feb 5
Avg volume 20D
29.3K
shares / day
Short interest
1.0K
≈0.0% of shares · −80.8%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
2
analyzed by SecBot
SecBot read MIXED 2 reports · 90 days
Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 1/2 ·Next Earnings date, Nov 10, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • X Jul 15 Short interest falls 77.5% to 4.5K
  • X Jul 31 Short interest jumps 423.1% to 23.8K
  • X Sep 15 Short interest falls 77.7% to 5.3K
  • X Sep 30 Short interest falls 80.8% to 1.0K

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 3 trimmed or exited.

  • Short sellersCOVERING

    Short interest −80.8% to 1.0K shares. 1.0 days to cover, ≈0.0% of shares.

  • TrendDOWNTREND

    11% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
RENAISSANCE TECHNOLOGIES LLCDOUBLED49,200$107.7K
JANE STREET GROUP, LLCNEAR_EXIT11,933$26.1K
VANGUARD FIDUCIARY TRUST COTRIM2,824$6.2K
UBS Group AGNEAR_EXIT656$1.4K
GEODE CAPITAL MANAGEMENT, LLCDOUBLED32,177$62.7K
UBS Group AGDOUBLED9,919$19.3K
CITIGROUP INCNEAR_EXIT1$2.00
OSAIC HOLDINGS, INC.NEAR_EXIT16$43.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Aug 2024
Recent actions
DateFirmActionRating
Aug 27, 2024Benchmark
REITERATE
REITERATESpeculative Buy
Jun 6, 2024Benchmark
MAINTAIN
MAINTAINSpeculative Buy
Apr 19, 2024Benchmark
MAINTAIN
MAINTAINSpeculative Buy
Jun 15, 2023Benchmark
REITERATE
REITERATESpeculative Buy
May 22, 2023Northland Capital Markets
INITIATE
INITIATEOutperform
Apr 18, 2023Benchmark
REITERATE
REITERATESpeculative Buy

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Sep 30, 2026
Burton Paul Frederick
Director
AWARD$6.2K
Sep 30, 2026
Intrater James
Director
AWARD$6.2K
Sep 30, 2026
Fung Peter K
Director
AWARD$6.2K
Sep 30, 2026
Betts Wendy J
Director
AWARD$6.2K
Jun 30, 2026
Burton Paul Frederick
Director
AWARD$6.3K
Jun 30, 2026
Fung Peter K
Director
AWARD$6.3K
Jun 30, 2026
Betts Wendy J
Director
AWARD$6.3K
Jun 30, 2026
Intrater James
Director
AWARD$6.3K

Earnings setup

Estimates
Nov 10
reports in 15 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
1,012
shares short
-80.8%
vs prior settlement
1.0
days to cover
≈0.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 Insider
Burton Paul Frederick was granted 3,286 shares
Director @ $1.90 ($6.2K)
Sep 30, 2026 Insider
Intrater James was granted 3,286 shares
Director @ $1.90 ($6.2K)
Sep 30, 2026 Insider
Fung Peter K was granted 3,286 shares
Director @ $1.90 ($6.2K)
Aug 20, 2026 SEC
Cardio Diagnostics Holdings, Inc. filed an 8-K with an investor presentation deck. The presentation highlights its…
8-K — Impact 2/10
Aug 12, 2026 Earnings calendar
CDIO Q2 2026 Earnings Scheduled — 2026-08-12
Aug 7, 2026 SEC
Cardio Diagnostics Holdings filed additional definitive proxy soliciting materials (DEFA14A) on August 7, 2026. The…
DEFA14A — Impact 2/10
Jun 30, 2026 Inst.
RENAISSANCE TECHNOLOGIES LLC — DOUBLED
49,200 shares ($107.7K)
Jun 30, 2026 Inst.
JANE STREET GROUP, LLC — NEAR_EXIT
11,933 shares ($26.1K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Aug 12, 2026
Earnings date
CDIO Q2 2026 Earnings Scheduled — 2026-08-12
May 13, 2026
Earnings date
CDIO Q1 2026 Earnings Scheduled — 2026-05-13
Mar 18, 2026
Earnings date
CDIO Q4 2025 Earnings Scheduled — 2026-03-18
Mar 16, 2026
Short interest
FTD: CDIO — 181,533 shares ($0.5M) failed to deliver
Settlement: 20260316, Price: $2.80, FTD Value: $508,292.4, CARDIO DIAGNOSTICS HLDGS INC C
Mar 2, 2026
Short interest
FTD: CDIO — 117,864 shares ($0.8M) failed to deliver
Settlement: 20260302, Price: $6.55, FTD Value: $772,009.2, CARDIO DIAGNOSTICS HLDGS INC C

SecBot reports

2 filings · 0 bullish · 0 bearish · 2 neutral
All CDIO filing & press-release reports (2)